Biography
Dr. Strickland earned a PhD in experimental pathology from the University of Virginia and completed postdoctoral fellowship training in clinical chemistry at the University of Virginia Medical Center in 2018.Sydney is a diplomat of the American Board of Clinical Chemistry (ABCC),and a member of American Association of Clinical Chemistry (AACC) and serves as a national co-discipline director of Biochemical Genetics. She serves on the board of the Pediatric-Maternal Fetal Division of AACC and as a committee member of the Evidence Based Laboratory Medicine Committee of AACC. She has authored more than 8 articles and abstracts published in such journals as Clinical Chemistry, Journal of Applied Laboratory Medicine (JALM), Clinica Chimica Acta. She holds a certificate of qualification from New York State Department of Health in Biochemical Genetics and Fetal Defect Markers.
Talk
Clinical Preeclampsia and Advances in Screening and Testing
"Value of early risk prediction, screening, & digital intervention in preterm birth avoidance" Speakers will discuss challenges of preterm birth, including preeclampsia, and highlight case studies from Ovia Health, a digital health intervention tool that can improve patient engagement, reduce preterm births and associated negative clinical and economic outcomes.
Track Co-Chairs:
Linda Giudice, UCSF
Yoel Sadovsky, UPMC
Researchers have long been recognizing the uniqueness of women’s health and its substantial effect on clinical practice, acknowledging the increasing appreciation of the importance of multidisciplinary approaches to health and disease. In every organ system, there are diseases that are unique to women, more common in women than in men, or characterized by differences in disease course in women compared to men. This Track will focus on the following topics related to Women’s Health: